v3.26.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Disaggregation of Revenue [Line Items]      
Net sales $ 6,020 $ 5,866  
Contract liabilities 1,035   $ 1,024
Orthopaedic Instruments      
Disaggregation of Revenue [Line Items]      
Net sales 489 484  
Other Orthopedics      
Disaggregation of Revenue [Line Items]      
Net sales 157 133  
Neuro Cranial Instruments      
Disaggregation of Revenue [Line Items]      
Net sales 606 563  
Enabling Technologies      
Disaggregation of Revenue [Line Items]      
Net sales $ 26 $ 29  
Customer Lease Agreements | Revenue Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 4.00% 4.00%